CRVS - Corvus Pharmaceuticals
Earnings Results

Corvus Pharmaceuticals ( $CRVS )

Recent earnings result

  1. Corvus Pharmaceuticals EPS misses by $0.06

Top Stories (CRVS)

Events & Annual meetings

There are no events at this time for this stock.


For list of CRVS events, you may visit their Investor Relations website.




Corvus Pharmaceuticals is a clinical science-driven biopharmaceutical company focused on the development of cleverly-designed medicines with precise mechanisms of action to improve the lives of patients with the most difficult-to-treat cancers, including refractory renal cell carcinoma and non-small cell lung cancer.


For list of CRVS events, you may visit their Investor Relations website.

Recent results

Books we are reading